Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
12/30/2008 | CA2245587C Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
12/30/2008 | CA2212207C Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |
12/25/2008 | US20080319073 Colonic delivery therapeutic agents for inflammatory bowel disease |
12/25/2008 | US20080319044 Compounds and Methods of Use Thereof |
12/25/2008 | US20080319042 Compositions and methods for treatment of liver disease |
12/25/2008 | US20080319013 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compounds |
12/25/2008 | US20080319012 2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors |
12/25/2008 | US20080319002 Xanthine Derivatives a Useful as Muscarinic Receptor Antagonists |
12/25/2008 | US20080318960 PAR2-modulating compounds and their use |
12/25/2008 | US20080318944 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
12/25/2008 | US20080318931 Treatment of Disorders and Diseases of the Colon |
12/25/2008 | US20080318910 Controlled-Release Oral Dosage Form |
12/25/2008 | US20080318897 Composition Containing Swelling Agent Composed of Swellable Water-Soluble Polysaccharide, and Food, Anti-Obesity Agent and Constipation Alleviator Each Containing the Composition |
12/25/2008 | US20080318856 administering a monomer protein comprising an amino acid sequence belonging to the TGF- beta super family, wherein alanine at position 83 is replaced with a serine, threonine or valine; protein induces differentiation of osteoblasts measured by promoting alkaline phosphatase activity to a patient |
12/25/2008 | US20080318852 Epitopes Related to Coeliac Disease |
12/25/2008 | US20080318293 Sulfotransferase Inhibitors |
12/25/2008 | US20080318275 Hepatitis C virus asialoglycoproteins |
12/25/2008 | US20080317855 Particulate Compositions Comprising Alginate and/or Alginic Acid |
12/25/2008 | US20080317821 Lipase Inhibitors |
12/25/2008 | US20080317726 Proteases for Pharmaceutical Use |
12/25/2008 | US20080317666 Colonic Delivery of Active Agents |
12/24/2008 | WO2008156102A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient |
12/24/2008 | WO2008156094A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient |
12/24/2008 | WO2008155920A1 Drug having effect of promoting hepatocyte growth |
12/24/2008 | WO2008155120A2 Methods and compositions for treating mucositis |
12/24/2008 | WO2008154868A1 Capsid proteins and uses therefore |
12/24/2008 | WO2008154817A1 Bromo-phenyl substituted thiazolyl dihydropyrimidines |
12/24/2008 | EP2005962A2 Therapeutic agent for inflammatory bowel disease |
12/24/2008 | EP2004646A2 Hydrochloride salts of 8-[{1-(3,5-bis-(trifluoromethyl) phenyl) -ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor |
12/24/2008 | EP2004235A2 Composition for cosmetic or pharmaceutical-dermatological use |
12/24/2008 | EP2004187A1 Dietary supplement for healing or regressing symptoms of gastroesophageal reflux disease, gastritis and ulcers |
12/24/2008 | EP2004186A2 Varenicline standards and impurity controls |
12/24/2008 | EP2004171A2 Treatments using citrulline |
12/24/2008 | EP2004164A1 Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases |
12/24/2008 | EP2004148A2 Pharmaceutical formulations: salts of 8-[{1-(3,5-bis (trifluoromethy1)pheny1)-e thoxy}-methy1]-8-pheny1-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same |
12/24/2008 | EP2003966A2 Anthracenedione compounds |
12/24/2008 | EP1503996B1 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors |
12/24/2008 | EP1373206B1 Aryl oxime-piperazines useful as ccr5 antagonists |
12/24/2008 | EP1178785B1 Compositions and methods for identifying antigens which elicit an immune response |
12/24/2008 | CN101330929A Inhibitor of transplanted islet dysfunction in islet transplantation |
12/24/2008 | CN101330920A Liquid medicine for internal use |
12/24/2008 | CN101330838A Method for preventing diseases in infants delivered via caesarean section |
12/24/2008 | CN101330837A Method for treating and/or preventing infections in infants delivered via caesarean section |
12/24/2008 | CN101330834A Methods and compositions for improving gastrointestinal health |
12/24/2008 | CN101328470A Rhamnose bacterium lacticum grx10 having cholesterol lowering and antibacterial functions, preparation and use thereof |
12/24/2008 | CN101328469A Streptococcus thermophilus grx02 having alcoholic liver damage protection function, preparation and use thereof |
12/24/2008 | CN101328220A Preparation and use of galactosylated human serum albumin fused interferon |
12/24/2008 | CN101328200A Antineoplastic compound, preparation and use thereof |
12/24/2008 | CN101328171A Bromophenyl-substituted thiazole dihydropyrimidine |
12/24/2008 | CN101328170A Fluorophenyl-substituted thiazole dihydropyrimidine |
12/24/2008 | CN101328169A Diethylcarbamyl-substituted thiazole dihydropyrimidine |
12/24/2008 | CN101328168A Diethylcarbamyl-substituted thiazole dihydropyrimidine |
12/24/2008 | CN101328162A Use of citrus aurtantium extract hydration meranzin for preparing gastrointestinal dynamic promoting drugs and preparation |
12/24/2008 | CN101328123A 5-oxo-substituted benzene acryloyl quinate methyl ester compound and use thereof |
12/24/2008 | CN101327323A Lyophilization technique for preparing lyophilized hepatitis A attenuated live vaccine |
12/24/2008 | CN101327320A Enzyme treatment for infection |
12/24/2008 | CN101327313A Oral medication for treating epigastric pain |
12/24/2008 | CN101327312A Chinese herbal medicine for treating cholecystitis |
12/24/2008 | CN101327293A Capsules for treating peptic ulcer and preparation method thereof |
12/24/2008 | CN101327278A Sang Ju heat-cleaning fire toxin-releasing king tea composition |
12/24/2008 | CN101327277A Heat-cleaning fire toxin-releasing king tea composition |
12/24/2008 | CN101327274A Chinese medicine gargle for treating toothache |
12/24/2008 | CN101327266A Oral cavity nursing agent for preventing and treating oral disease induced by Helicobacter pylori infection contamination |
12/24/2008 | CN101327263A Use of stasis-dispersing medicament composition in preparing medicament for treating abdominal cavity adhesion peritonitis |
12/24/2008 | CN101327262A Qingkailing suppositorium |
12/24/2008 | CN101327261A Auxiliary drink for treating constipation |
12/24/2008 | CN101327247A Senna formulation and quality control method |
12/24/2008 | CN101327246A Radix astragali medicinal materials, intermediate body and method for testing fingerprint of formulation thereof as well as standard fingerprint |
12/24/2008 | CN101327244A Decolored and debitterized Momordica grosvenori extract and preparation method thereof |
12/24/2008 | CN101327225A Bee honey acid composition and preparation method and uses thereof |
12/24/2008 | CN101327220A Use of pseudo-ginseng saponin R1 in preparing medicament for treating liver damage |
12/24/2008 | CN101327209A Dihydromyricetin injection, powder injection and preparation method thereof |
12/24/2008 | CN101327204A Use of emodic acid in preventing and treating fatty liver |
12/24/2008 | CN101327018A Health drink and method for producing the same |
12/24/2008 | CN101327009A Liver-boosting cold tea and preparation thereof |
12/24/2008 | CN101327004A Health food for regulating blood fat and improving gastrointestinal tract function and preparation method thereof |
12/24/2008 | CN101327000A Novel use of bamboo shell extract |
12/24/2008 | CN101326976A Cake for strengthening spleen and stimulating appetite |
12/24/2008 | CN101326945A Jujube chestnut leaf tea |
12/24/2008 | CN101326944A Burdock and coix seed tea prescription and processing technique |
12/24/2008 | CN100444879C A method for preparing sugar-free granule with astragalus root, dendrobium stem and haw thorn fruit |
12/24/2008 | CN100444877C A Chinese medicine for treating cholecystitis |
12/24/2008 | CN100444866C Synergistic medicinal composition |
12/24/2008 | CN100444865C Synergistic medicinal composition containing dicyclic alcohol |
12/24/2008 | CN100444855C Orally taken medicine powder for treating diarrhea |
12/24/2008 | CN100444853C Transaminase lowering dripping pill and its prepn |
12/24/2008 | CN100444845C Biologic adhesion preparation of total saponin of notoginseng for gastrointestinal tract |
12/24/2008 | CN100444844C Composition for repairing and promoting regeneration of gastrointestinal tract mucous tissue and its preparation method thereof |
12/24/2008 | CN100444839C Treatment of chemokine mediated diseases |
12/24/2008 | CN100444734C A compound antivirus sprayer and preparation method thereof |
12/24/2008 | CA2726420A1 Topical dental solution of chlorhexidine in sumatra benzoin bp/ep and methods of manufacturing and evaluating same for compliance with international regulatory specifications |
12/24/2008 | CA2692249A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient |
12/24/2008 | CA2692248A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient |
12/24/2008 | CA2691056A1 Bromo-phenyl substituted thiazolyl dihydropyrimidines for treating and preventing hepatitis b infections |
12/24/2008 | CA2691033A1 Capsid proteins and uses therefore |
12/24/2008 | CA2689658A1 Methods and compositions for treating mucositis |
12/23/2008 | US7468385 Preterm labor, premature birth, dysmenorrhea, inappropriate secretion of vasopressin, congestive heart failure, arterial hypertension, liver cirrhosis, nephrotic syndrome and ocular hypertension; 3-(5-((3-chlorobenzyl)sulfanyl)-4-(3-methoxypropyl)-4H-1,2,4-triazol-3-yl)-N-(2-methoxybenzyl)propanamide |
12/23/2008 | US7468367 depression; anxiety; addictions; obsessive compulsive disorder; affective neurosis/disorder; depressive neurosis/disorder, anxiety neurosis; dysthymic disorder; behaviour disorder; mood disorder; sexual dysfunction; psychosexual dysfunction; sex disorder, sexual disorder; schizophrenia; manic depression; |
12/23/2008 | US7468361 For therapy of skin conditions selected from the group consisting of dermatitis, eczema, keratosis, lack of skin firmness, wrinkles, lack of dermal hydration and insufficient sebum secretion |
12/23/2008 | US7468359 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |